Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin tyrosine ligase like 4 (TTLL4) is an enzyme belonging to the tubulin tyrosine ligase-like (TTLL) family, primarily functioning as a monoglutamylase. It initiates polyglutamylation—a posttranslational modification that adds a single glutamate residue to the γ-carboxyl group of specific glutamate residues on tubulin and various non-tubulin targets, such as nucleosome assembly proteins (NAP1L1, NAP1L4), the nucleotidyltransferase CGAS, and the transcription factor KLF4. TTLL4 is classified as an initiator, not an elongator of polyglutamate side chains, acting preferentially but not exclusively on the β-tail of tubulin substrates. The enzyme plays crucial roles in microtubule cytoskeleton organization, maintenance of ciliary function, neurodevelopment, and regulation of innate immune responses by modifying key proteins. Loss of regulation in polyglutamylation by TTLL4 and related enzymes is implicated in neurodegenerative processes and certain developmental disorders. TTLL4 acts in the cytosol and is expressed in various brain regions, with tissue-specific functions highlighted by distinct substrate isoform preferences.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin tyrosine ligase like 4 (TTLL4).